摘要
目的分析前列腺特异性抗原异常的前列腺增生患者穿刺及术后病理特征。方法将该院于2014年1月—2019年1月阶段收治的100例前列腺特异性抗原异常的前列腺增生患者作为该次研究的对象,对患者病理特征,血清PSA水平,年龄,前列腺体积以及移行区体积等相关资料进行回顾性分析。结果患者血清PSA水平为4~10 ng/mL,11~15 ng/mL,16~20 ng/mL,>20 ng/mL时,穿刺病理分布中单纯增生所占的比例分别为39.2%、32.2%、27.7%、21.7%,炎症所占比例分别为28.5%、39.0%、44.4%、47.8%,术后病理分布上皮内瘤变所占比例分别为;32.1%、39.0%、50.0%、60.8%,可知PSA升高与单纯增生为反比关系,与炎症以及上皮内瘤变为正比关系。结论对前列腺增生患者血清中PSA异常与病理分布关系密切,而上皮内瘤变与炎症可能导致患者血清PSA升高。
Objective To analyze the puncture and postoperative pathological characteristics of patients with benign prostatic hyperplasia with abnormal prostate-specific antigen.Methods 100 patients with benign prostate hyperplasia with abnormal prostate-specific antigen treated in the hospital from January 2014 to January 2019 were taken as the subjects of this study.The pathological characteristics,serum PSA level,age,prostate volume,and relevant data such as the transition zone volume were analyzed retrospectively.Results The serum PSA levels of patients were 4-10 ng/mL,11-15 ng/mL,16-20 ng/mL,and>20 ng/mL.In the patld gical,distribution of puncture the proportion of simple hyperplasia was 39.2%,32.2%,27.7%,and 21.7%,respectively.The proportion of inflammation was 28.5%,39.0%,44.4%,47.8%,and in the postoperative pathological distribution,the proportion in the postoperative pathological distribution of intraepithelial neoplasia was 32.1%,39.0%,50.0%,and 60.8%.It can be seen that PSA increase is inversely proportional to pure hyperplasia.The relationship was directly proportional to inflammation and intraepithelial neoplasia.Conclusion The abnormality of PSA in the serum of patients with benign prostatic hyperplasia is closely related to the pathological distribution,and intraepithelial neoplasia and inflammation may lead to the increase of serum PSA in patients.
作者
周福安
纪海勇
张志明
杜翠霞
闫晓东
李艳雪
ZHOU Fu-an;JI Hai-yong;ZHANG Zhi-ming;DU Cui-xia;YAN Xiao-dong;LI Yan-xue(Department of Pathology,Ningjin County People's Hospital,Dezhou,Shandong Province,253400 China)
出处
《系统医学》
2020年第2期25-27,共3页
Systems Medicine
关键词
前列腺特异性抗原
前列腺增生
病理特征
Prostate-specific antigen
Prostate hyperplasia
Pathological characteristics
